Back

Early intensive combination lipid-lowering therapy in statin-naïve acute coronary syndrome: real-world attainment of lipid targets and analysis of therapeutic gaps

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes treatment optimisation Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Guang Ming Tan

The Chinese University of Hong Kong, Shatin (Hong Kong)

4 More presentations in this session

Presentation thumbnail
Long-term beta-blocker therapy after revascularised acute coronary syndrome (ACS) with preserved ejection fraction: a multi-centre retrospective cohort study
Doctor J. Tan (Chiayi, TW)
Abstract
Presentation thumbnail
Upfront combination lipid-lowering therapy in acute coronary syndrome: a bayesian network meta-analysis of low-density lipoprotein cholesterol reduction and major adverse cardiovascular events
Mr P. Sanjayanthan Keerthi (Chennai, IN)
Abstract
Presentation thumbnail
Antithrombotic strategies in conservatively managed patients with spontaneous coronary artery dissection
Doctor D. Wussler (Basel, CH)
Abstract
Presentation thumbnail
Benefit of upfront combination lipid-lowering therapy in statin-naïve acute coronary syndrome patients with intermediate admission LDL-C and Lp(a)-driven predicted monotherapy failure
Doctor F. Buendia Santiago (Cartagena, ES)
Abstract

Access the full session

Session thumbnail
Acute coronary syndromes treatment optimisation

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Real-world use of rosuvastatin 40 mg and ezetimibe 10 mg after ACS: is this combination effective in achieving guideline-recommended LDL-C goals after discharge?
20 March 2026
thumbnail
Congress Presentation
Blood pressure and LDL-cholesterol control in patients with primary hypertension is far from optimal: results from a large observational, multicentric, prospective study
1 September 2019
thumbnail
Congress Session
For high-risk patients it's 15 minutes to midnight on the acute coronary syndrome (ACS) clock: can we stop it?
31 August 2024
thumbnail
Congress Presentation
Age-stratified analysis of real-world lipid-lowering therapy use and LDL-C goal attainment at 1-year follow-up: insights from the European SANTORINI study
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources